Your browser doesn't support javascript.
loading
The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolution.
Puig, N; Conde, I; Jiménez, C; Sarasquete, M E; Balanzategui, A; Alcoceba, M; Quintero, J; Chillón, M C; Sebastián, E; Corral, R; Marín, L; Gutiérrez, N C; Mateos, M-V; González-Díaz, M; San-Miguel, J F; García-Sanz, R.
Afiliación
  • Puig N; 1] Department of Hematology, University Hospital of Salamanca, Salamanca, Spain [2] IBSAL, Salamanca, Spain [3] IBMCC (USAL-CSIC), Salamanca, Spain.
  • Conde I; 1] Department of Hematology, University Hospital of Salamanca, Salamanca, Spain [2] IBSAL, Salamanca, Spain [3] IBMCC (USAL-CSIC), Salamanca, Spain.
  • Jiménez C; 1] Department of Hematology, University Hospital of Salamanca, Salamanca, Spain [2] IBSAL, Salamanca, Spain [3] IBMCC (USAL-CSIC), Salamanca, Spain.
  • Sarasquete ME; 1] Department of Hematology, University Hospital of Salamanca, Salamanca, Spain [2] IBSAL, Salamanca, Spain [3] IBMCC (USAL-CSIC), Salamanca, Spain.
  • Balanzategui A; 1] Department of Hematology, University Hospital of Salamanca, Salamanca, Spain [2] IBSAL, Salamanca, Spain [3] IBMCC (USAL-CSIC), Salamanca, Spain.
  • Alcoceba M; 1] Department of Hematology, University Hospital of Salamanca, Salamanca, Spain [2] IBSAL, Salamanca, Spain [3] IBMCC (USAL-CSIC), Salamanca, Spain.
  • Quintero J; Department of Hematology, Hospital Miguel Servet, Zaragoza, Spain.
  • Chillón MC; 1] Department of Hematology, University Hospital of Salamanca, Salamanca, Spain [2] IBSAL, Salamanca, Spain [3] IBMCC (USAL-CSIC), Salamanca, Spain.
  • Sebastián E; 1] Department of Hematology, University Hospital of Salamanca, Salamanca, Spain [2] IBSAL, Salamanca, Spain [3] IBMCC (USAL-CSIC), Salamanca, Spain.
  • Corral R; 1] Department of Hematology, University Hospital of Salamanca, Salamanca, Spain [2] IBSAL, Salamanca, Spain [3] IBMCC (USAL-CSIC), Salamanca, Spain.
  • Marín L; 1] Department of Hematology, University Hospital of Salamanca, Salamanca, Spain [2] IBSAL, Salamanca, Spain [3] IBMCC (USAL-CSIC), Salamanca, Spain.
  • Gutiérrez NC; 1] Department of Hematology, University Hospital of Salamanca, Salamanca, Spain [2] IBSAL, Salamanca, Spain [3] IBMCC (USAL-CSIC), Salamanca, Spain.
  • Mateos MV; 1] Department of Hematology, University Hospital of Salamanca, Salamanca, Spain [2] IBSAL, Salamanca, Spain [3] IBMCC (USAL-CSIC), Salamanca, Spain.
  • González-Díaz M; 1] Department of Hematology, University Hospital of Salamanca, Salamanca, Spain [2] IBSAL, Salamanca, Spain [3] IBMCC (USAL-CSIC), Salamanca, Spain.
  • San-Miguel JF; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain.
  • García-Sanz R; 1] Department of Hematology, University Hospital of Salamanca, Salamanca, Spain [2] IBSAL, Salamanca, Spain [3] IBMCC (USAL-CSIC), Salamanca, Spain.
Leukemia ; 29(6): 1435-7, 2015 Jun.
Article en En | MEDLINE | ID: mdl-25567133
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cadenas Pesadas de Inmunoglobulina / Regiones Determinantes de Complementariedad / Mieloma Múltiple Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cadenas Pesadas de Inmunoglobulina / Regiones Determinantes de Complementariedad / Mieloma Múltiple Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido